Floatz logo

Anti-Thymoglobulin, Rabbit

Recurrent Marginal Zone Lymphoma

Emory UniversityPhase 2Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

22 Active assets in the Recurrent Marginal Zone Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
University of Miami
Phase 2BBB
Fludarabine
Paolo Caimi, MD
Phase 2BBB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 2BBB
FILGRASTIM
Fred Hutchinson Cancer Center
Phase 2BBB
Cediranib
City of Hope Medical Center
Phase 2BB

View all 50 →

Same molecule, other indications

Anti-Thymoglobulin, Rabbit is also rated in:

myelodysplastic/myeloproliferative neoplasmDormant
BBB
Indicative ·
75 / 100
View asset →
plasma cell myelomaDormant
BBB
Indicative ·
72 / 100
View asset →
myeloproliferative neoplasmDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →